Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

NCT06863259 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

DRUG: Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone

Sponsor

Children's Hospital Medical Center, Cincinnati